We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.225 | 5.81% | 4.10 | 4.05 | 4.15 | 4.275 | 3.825 | 3.88 | 29,115,559 | 16:25:52 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -4.32 | 21.05M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 24/7/2024 15:36 | Good luck, mind you; PH have loads to dump; they are dumping on the rise. Regards, F911 RMC | firestorm911 | |
| 24/7/2024 15:34 | That's a long and interesting post Hazl, but can I ask you keep things on topic please.Best wishes,Your Pal Beeksy of Harehills | premium beeks | |
| 24/7/2024 15:31 | People have to do their own research. I will not answer people who berate others, yet who cannot be bothered to do their own hard work, or lack the skills to do so. The mention on the NICE website much earlier in the year gave advice on costs from memory. Again my thoughts are the huge numbers of people suffering strokes in countries everywhere, and the units that are supplied to a department means they will cover many people, should they be needed I imagine. Why the sniping? Not needed. Petersinthemarket is no loss to me, but it is the second time he has felt the need to say it. I can only assume it is petty jealousy and an inability to see who the genuine investors are. I have a core position. FWIW. I am not a big investor just someone who enjoys learning about new and innovative shares. IMO | hazl | |
| 24/7/2024 15:27 | It's confirmed by NICE that publication as per the website ie 31/07/2024. Expect fireworks next week. The share price of 8p to 10p at the minimum | z1co | |
| 24/7/2024 15:18 | From investing.com In conclusion, Genedrive PLC has navigated a complex landscape in 2024 with a mix of achievements and challenges. The company's innovative products, strategic partnerships, and commitment to expanding its market reach are promising indicators of future success. While market volatility remains a concern, the long-term outlook for Genedrive appears positive, making it a company to watch closely as it continues to evolve in the rapidly changing healthcare diagnostics sector. As we move forward, staying informed about Genedrive's developments and market conditions will be crucial for investors. With a focus on innovation and global health, Genedrive is poised to make significant contributions to the healthcare industry, potentially driving substantial value for its stakeholders. | hazl | |
| 24/7/2024 15:07 | 4.28 resistance, a hard nut to crack atm, but it will go. chart looks good fwiw | minja19 | |
| 24/7/2024 14:49 | The long term chart is indicating 8p to 10p Lets just wait for the approval next Wednesday and we'll see how high the price RISES | z1co | |
| 24/7/2024 14:45 | Does the chart predict the future? Regards, F911 RMC | firestorm911 | |
| 24/7/2024 14:27 | On every positive rns over the last few years the share price at least doubled the same will happen again next week. | z1co | |
| 24/7/2024 14:24 | At the moment the only thing that matters is approval of their CYP2C19-ID Test. Upon APPROVAL next week expect the shares to RISE STRONGLY and breach 10p | z1co | |
| 24/7/2024 14:24 | 5p looks a dead cert approaching month end !Would have been extra lolly in your pot ;) | kubera369 | |
| 24/7/2024 14:15 | Good post, Batiatus. I am staying out here. Took off at an average of 4.55p. We have all exited. Regards F911 RMC | firestorm911 | |
| 24/7/2024 14:04 | From next week the company will have TWO world class products approved to sell to hospitals both in the UK and many countries all over the world. Capped at only £20m still very very CHEAP. Fair value of £100m plus | z1co | |
| 24/7/2024 13:55 | Into the 5's today/tomorrow. The charts never lie. | socionomics | |
| 24/7/2024 13:49 | It's too risky for me at this price; good luck to anyone holding it or shorting. It could be -90% or + 50%. Regards, F911 RMC | firestorm911 | |
| 24/7/2024 13:41 | MM's taking a few more from the weak traders before taking the price HIGHER | z1co | |
| 24/7/2024 13:32 | I'm really surprised the shares are still below 5p !!! Confirmed NICE will publish the out come for CYP2C19-ID Test next Wednesday. APPROVAL is just a formality | z1co | |
| 24/7/2024 13:25 | Buying reduced even further to just 50,000 @ 4.20p and it's NT above that | z1co | |
| 24/7/2024 13:23 | Remember folks it's now confirmed that NICE publication is on track for next Wednesday | z1co | |
| 24/7/2024 13:22 | No quote to buy 150,000 @ 4.20p | z1co | |
| 24/7/2024 13:17 | BLUR BY COP | z1co |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
